Sintx Technologies, Inc. Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation
Sintx Technologies, Inc. (SINT) had Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation of $384.00 thousand as of 2025-02-19, per its 10-K filed 2026-03-20.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Liability Assumed, Liability
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation · last filed 2026-03-20
- 2025-02-19: Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation $384.00K.
| Period end | Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation |
|---|---|
| 2025-02-19 | $384.00K 10-K · filed 2026-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |